Market Overview:
The global vinca alkaloid compounds market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, growing demand for chemotherapy drugs, and rising investments by pharmaceutical companies in R&D activities. Based on type, the global vinca alkaloid compounds market is segmented into Vinblastine, Vincristine, Vinorelbine, and Vindesine. Of these segments, Vinblastine held the largest share of the market in 2017 owing to its high demand for treating various types of cancers such as Hodgkin’s lymphoma and testicular cancer. By application, hospitals accounted for the majority share of this market in 2017 due to increased use of chemotherapy drugs for treatment purposes in hospitals across the globe.
Product Definition:
Vinca alkaloid compounds are a group of plant-based chemicals that have been shown to have anticancer properties. They are derived from the periwinkle plant, which has been used for centuries in traditional medicine to treat a variety of illnesses. Today, vinca alkaloids are being studied as potential treatments for various types of cancer.
Vinblastine:
Vinblastine, also known as vincristine, is a medication used for the treatment of cancer. It works by damaging the cells that divide rapidly and thus prevents them from growing or reproducing. Vinblastine can be used with other medications to treat different types of cancers such as lymphoma and leukemia.
Vincristine:
Vincristine is a semi-synthetic alkaloid derived from the European periwinkle plant, Vinca rosea. It was first isolated in 1931 by an Italian physician, Dr. Giorgio Fieschi and named as vinblastine.
Application Insights:
The market is segmented by application into hospitals, clinics, and diagnostic centers. The hospitals segment dominated the global market in 2017 owing to increasing cancer cases across the globe. According to WHO, around 1 in 6 people dies from cancer. Various governments are taking initiatives for early diagnosis and treatment of various cancers including lung, breast and colorectal cancers which has increased demand for vinca alkaloids-based drugs which are primarily used in chemotherapy. This is expected to drive growth over the forecast period.
Clinical trials held key importance during the launch of any new drug candidate as it plays a vital role in determining whether a new drug will be safe & effective for use within clinical settings as well as outside of them (i.e., real world).
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players and well-established healthcare infrastructure. The region is expected to maintain its dominance over the forecast period due to increasing R&D activities and introduction of new products. In addition, rising incidence rates of cancer are also anticipated to boost growth during the forecast period.
Asia Pacific is expected to witness lucrative growth over the next eight years owing with rapid economic development coupled with improving healthcare facilities in emerging countries such as China, India, South Korea & Japan. Furthermore, growing awareness about advanced treatment options for various cancers is further anticipated fuel regional demand during the forecast period (2018 - 2030).
Growth Factors:
- Increasing demand for anticancer drugs: The global market for anticancer drugs is expected to grow at a CAGR of 7.5% from 2016 to 2021. This growth can be attributed to the increasing incidence of cancer, growing awareness about cancer and its treatment, and the launch of novel therapeutics. Vinca alkaloid compounds are used as key ingredients in many anticancer drugs and hence this market growth will benefit the vinca alkaloid compounds market as well
- Rising prevalence of chronic diseases: The prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is rising globally due to changing lifestyles and aging populations. This is leading to an increase in the demand for effective treatments such as vinca alkaloid compounds-based therapies
- Growing focus on targeted therapies: The trend toward targeted therapies is resulting in an increased demand for vinca alkaloid compound-based therapies that specifically target tumor cells without affecting healthy cells nearby. This trend will help drive the growth of the vinca alkaloid compounds market in coming years
- Technological advancements in drug discovery: Drug discovery technologies are evolving rapidly with new methods being developed for identifying potential drug targets and developing novel therapeutics faster than ever before. This has led to an increased interest in using vinca alkaloids as lead molecules for developing new therapeutic agents, which will help drive growth in this market over time
Scope Of The Report
Report Attributes
Report Details
Report Title
Vinca Alkaloid Compounds Market Research Report
By Type
Vinblastine, Vincristine, Vinorelbine, Vindesine
By Application
Hospitals, Clinics, Diagnostic Centers
By Companies
Pierre Fabre, Minakem, Guangzhou Hanfang Pharmaceutical, Hainan Vinca biological medicine technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, Hubei Honch Pharmaceutical, Fine Chemicals Corporation, Vinkem, Hansoh, Min Sheng, Zhendong Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Vinca Alkaloid Compounds Market Report Segments:
The global Vinca Alkaloid Compounds market is segmented on the basis of:
Types
Vinblastine, Vincristine, Vinorelbine, Vindesine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostic Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pierre Fabre
- Minakem
- Guangzhou Hanfang Pharmaceutical
- Hainan Vinca biological medicine technology
- Guangzhou Person Pharmaceutical
- Hainan Yueyang Biotechnology
- Hubei Honch Pharmaceutical
- Fine Chemicals Corporation
- Vinkem
- Hansoh
- Min Sheng
- Zhendong Group
Highlights of The Vinca Alkaloid Compounds Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Vinblastine
- Vincristine
- Vinorelbine
- Vindesine
- By Application:
- Hospitals
- Clinics
- Diagnostic Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Vinca Alkaloid Compounds Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Vinca alkaloid compounds are a type of plant-based drug that can be used to treat a variety of medical conditions. These compounds work by interfering with the activity of certain proteins in the body, which can lead to improved symptoms.
Some of the major players in the vinca alkaloid compounds market are Pierre Fabre, Minakem, Guangzhou Hanfang Pharmaceutical, Hainan Vinca biological medicine technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, Hubei Honch Pharmaceutical, Fine Chemicals Corporation, Vinkem, Hansoh, Min Sheng, Zhendong Group.
The vinca alkaloid compounds market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Vinca Alkaloid Compounds Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Vinca Alkaloid Compounds Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Vinca Alkaloid Compounds Market - Supply Chain
4.5. Global Vinca Alkaloid Compounds Market Forecast
4.5.1. Vinca Alkaloid Compounds Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Vinca Alkaloid Compounds Market Size (000 Units) and Y-o-Y Growth
4.5.3. Vinca Alkaloid Compounds Market Absolute $ Opportunity
5. Global Vinca Alkaloid Compounds Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Vinca Alkaloid Compounds Market Size and Volume Forecast by Type
5.3.1. Vinblastine
5.3.2. Vincristine
5.3.3. Vinorelbine
5.3.4. Vindesine
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Vinca Alkaloid Compounds Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Vinca Alkaloid Compounds Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Diagnostic Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Vinca Alkaloid Compounds Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Vinca Alkaloid Compounds Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Vinca Alkaloid Compounds Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Vinca Alkaloid Compounds Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Vinca Alkaloid Compounds Demand Share Forecast, 2019-2026
9. North America Vinca Alkaloid Compounds Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Vinca Alkaloid Compounds Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Vinca Alkaloid Compounds Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Diagnostic Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Vinca Alkaloid Compounds Market Size and Volume Forecast by Type
9.7.1. Vinblastine
9.7.2. Vincristine
9.7.3. Vinorelbine
9.7.4. Vindesine
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Vinca Alkaloid Compounds Demand Share Forecast, 2019-2026
10. Latin America Vinca Alkaloid Compounds Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Vinca Alkaloid Compounds Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Vinca Alkaloid Compounds Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Diagnostic Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Vinca Alkaloid Compounds Market Size and Volume Forecast by Type
10.7.1. Vinblastine
10.7.2. Vincristine
10.7.3. Vinorelbine
10.7.4. Vindesine
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Vinca Alkaloid Compounds Demand Share Forecast, 2019-2026
11. Europe Vinca Alkaloid Compounds Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Vinca Alkaloid Compounds Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Vinca Alkaloid Compounds Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Diagnostic Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Vinca Alkaloid Compounds Market Size and Volume Forecast by Type
11.7.1. Vinblastine
11.7.2. Vincristine
11.7.3. Vinorelbine
11.7.4. Vindesine
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Vinca Alkaloid Compounds Demand Share, 2019-2026
12. Asia Pacific Vinca Alkaloid Compounds Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Vinca Alkaloid Compounds Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Vinca Alkaloid Compounds Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Diagnostic Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Vinca Alkaloid Compounds Market Size and Volume Forecast by Type
12.7.1. Vinblastine
12.7.2. Vincristine
12.7.3. Vinorelbine
12.7.4. Vindesine
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Vinca Alkaloid Compounds Demand Share, 2019-2026
13. Middle East & Africa Vinca Alkaloid Compounds Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Vinca Alkaloid Compounds Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Vinca Alkaloid Compounds Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Diagnostic Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Vinca Alkaloid Compounds Market Size and Volume Forecast by Type
13.7.1. Vinblastine
13.7.2. Vincristine
13.7.3. Vinorelbine
13.7.4. Vindesine
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Vinca Alkaloid Compounds Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Vinca Alkaloid Compounds Market: Market Share Analysis
14.2. Vinca Alkaloid Compounds Distributors and Customers
14.3. Vinca Alkaloid Compounds Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pierre Fabre
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Minakem
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Guangzhou Hanfang Pharmaceutical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Hainan Vinca biological medicine technology
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Guangzhou Person Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Hainan Yueyang Biotechnology
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hubei Honch Pharmaceutical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Fine Chemicals Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Vinkem
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Hansoh
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Min Sheng
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Zhendong Group
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
